$BANT
Bantec, Inc. Stock $bant

$bant Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023039539 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$590.3K	$623.1K	$369.9K
YoY Change	-21.37%	68.45%	-44.37%
Cost Of Revenue	$489.8K	$514.9K	$322.1K
YoY Change	-22.13%	59.9%	-29.23%
Gross Profit	$100.5K	$108.2K	$47.86K
YoY Change	-17.43%	126.03%	-77.19%
Gross Profit Margin	17.03%	17.36%	12.94%
Selling, General & Admin	$397.4K	$481.5K	$547.5K
YoY Change	-15.57%	-12.06%	-21.62%
% of Gross Profit	395.34%	445.09%	1144.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00		$0.00
YoY Change	-100.0%		-100.0%
% of Gross Profit	0.0%		0.0%
Operating Expenses	$397.4K	$481.5K	$547.5K
YoY Change	-16.75%	-12.06%	-21.9%
Operating Profit	-$296.8K	-$373.3K	-$499.7K
YoY Change	-16.52%	-25.29%	1.73%
Interest Expense	-$346.5K	-$457.4K	-$298.1K
YoY Change	32.5%	53.41%	2.35%
% of Operating Profit
Other Income/Expense, Net	-$346.5K	-$457.4K	-$223.0K
YoY Change	240.81%	105.07%
Pretax Income	-$643.4K	-$830.7K	-$722.7K
YoY Change	40.7%	14.94%	244.16%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$643.4K	-$830.7K	-$722.7K
YoY Change	40.7%	14.94%	244.16%
Net Earnings / Revenue	-108.99%	-133.31%	-195.37%
Basic Earnings Per Share	-$0.10	$0.00	$0.00
Diluted Earnings Per Share	-$0.10	$0.00	-$230.40
COMMON SHARES
Basic Shares Outstanding	6.994B shares	6.621B shares	3.137B shares
Diluted Shares Outstanding	6.994M shares	6.527B shares	3.137B shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.77K	$10.15K	$387.8K
YoY Change	-82.0%	-97.38%	67.6%
Cash & Equivalents	$43.77K	$10.15K	$387.8K
Short-Term Investments
Other Short-Term Assets	$34.53K	$4.660K	$4.930K
YoY Change	640.99%	-5.48%	-33.47%
Inventory	$55.12K	$83.84K	$122.2K
Prepaid Expenses
Receivables	$268.2K	$299.4K	$169.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$401.6K	$398.0K	$684.4K
YoY Change	-36.52%	-41.85%	22.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.461K	$1.461K	$61.12K
YoY Change	0.0%	-97.61%	-47.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$119.7K
YoY Change
Total Long-Term Assets	$142.0K	$8.904K	$225.4K
YoY Change	-30.95%	-96.05%	94.36%
TOTAL ASSETS
Total Short-Term Assets	$401.6K	$398.0K	$684.4K
Total Long-Term Assets	$142.0K	$8.904K	$225.4K
Total Assets	$543.6K	$406.9K	$909.8K
YoY Change	-35.15%	-55.28%	34.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.668M	$2.717M	$2.668M
YoY Change	-1.31%	1.85%	-0.85%
Accrued Expenses	$6.258M	$5.881M	$4.765M
YoY Change	25.08%	23.42%	16.67%
Deferred Revenue
YoY Change
Short-Term Debt	$8.591M	$8.407M	$855.0K
YoY Change	915.52%	883.22%	-7.97%
Long-Term Debt Due	$523.9K	$324.4K	$7.546M
YoY Change	-93.03%	-95.7%	-7.59%
Total Short-Term Liabilities	$18.47M	$17.46M	$15.99M
YoY Change	13.37%	9.18%	-0.42%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$150.0K	$287.1K
YoY Change	15.35%	-47.76%	-5.79%
Other Long-Term Liabilities	$100.3K		$9.810K
YoY Change			-83.89%
Total Long-Term Liabilities	$250.3K	$150.0K	$296.9K
YoY Change	92.44%	-49.48%	-18.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.47M	$17.46M	$15.99M
Total Long-Term Liabilities	$250.3K	$150.0K	$296.9K
Total Liabilities	$18.73M	$17.61M	$16.29M
YoY Change	13.99%	8.11%	-0.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.89M	-$37.24M
YoY Change	8.28%
Common Stock	$699.00	$699.4K
YoY Change	-99.82%
Preferred Stock	$111.6K	$76.69K
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$18.64M	-$17.96M	-$15.38M
YoY Change
Total Liabilities & Shareholders Equity	$543.6K	$406.9K	$909.8K
YoY Change	-35.15%	-55.28%	34.82%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$643.4K	-$830.7K	-$722.7K
YoY Change	40.7%	14.94%	244.16%
Depreciation, Depletion And Amortization	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Cash From Operating Activities	-$159.1K	-$187.2K	-$635.7K
YoY Change	-37.68%	-70.55%	8.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	192.7K	102.4K	241.7K
YoY Change	74.26%	-57.62%	-64.38%
NET CHANGE
Cash From Operating Activities	-159.1K	-187.2K	-635.7K
Cash From Investing Activities
Cash From Financing Activities	192.7K	102.4K	241.7K
Net Change In Cash	33.62K	-84.79K	-393.9K
YoY Change	-123.23%	-78.48%	-525.26%
FREE CASH FLOW
Cash From Operating Activities	-$159.1K	-$187.2K	-$635.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	Bantec, Inc.
	dei	Security Exchange Name SecurityExchangeName	NONE
	dei	City Area Code CityAreaCode	(203)
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55789
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0967943
	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 Paterson Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Falls
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07424
	dei	Local Phone Number LocalPhoneNumber	220-2296
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12g Title Security12gTitle	Common
	dei	Trading Symbol TradingSymbol	BANT
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6993994532	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10149	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	186386	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	299350	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	419951	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	83838	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	92917	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4663	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4663	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	398000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	703917	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1461	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1461	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7443	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33568	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	8904	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	35029	usd
CY2023Q1	us-gaap	Assets Assets	406904	usd
CY2022Q3	us-gaap	Assets Assets	738946	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2717147	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2730309	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5880856	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5094394	usd
CY2023Q1	bant	Convertible Notes Payable Net Of Discounts And Premiums ConvertibleNotesPayableNetOfDiscountsAndPremiums	7470325	usd
CY2022Q3	bant	Convertible Notes Payable Net Of Discounts And Premiums ConvertibleNotesPayableNetOfDiscountsAndPremiums	7422326	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	834000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	837000	usd
CY2023Q1	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	324406	usd
CY2022Q3	bant	Notes And Loan Payable Current NotesAndLoanPayableCurrent	217897	usd
CY2023Q1	bant	Notes Payable Related Parties NotesPayableRelatedParties	102170	usd
CY2022Q3	bant	Notes Payable Related Parties NotesPayableRelatedParties	13537	usd
CY2023Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	122340	usd
CY2022Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	154562	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7670	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34475	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17458914	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16504500	usd
CY2023Q1	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	150000	usd
CY2022Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	127539	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	150000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	127539	usd
CY2023Q1	us-gaap	Liabilities Liabilities	17608914	usd
CY2022Q3	us-gaap	Liabilities Liabilities	16632039	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	762133	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	685440	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6993994532	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6993994532	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4407320832	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4407320832	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	699400	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-722704	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	440733	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18578986	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18610920	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37242529	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35630186	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-17964143	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-16578533	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	406904	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	738946	usd
CY2023Q1	us-gaap	Revenues Revenues	623123	usd
CY2022Q1	us-gaap	Revenues Revenues	369908	usd
	us-gaap	Revenues Revenues	1229289	usd
	us-gaap	Revenues Revenues	772025	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	514946	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	322053	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1026162	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	629353	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	108177	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	47855	usd
	us-gaap	Gross Profit GrossProfit	203127	usd
	us-gaap	Gross Profit GrossProfit	142672	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	481483	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	547529	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	995773	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1201825	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	481483	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	547529	usd
	us-gaap	Operating Expenses OperatingExpenses	995773	usd
	us-gaap	Operating Expenses OperatingExpenses	1201825	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-373306	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-499674	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-792646	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1059153	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	11424	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	12101	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	75087	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	75087	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-457362	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-309541	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-819697	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-603711	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-457362	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-223030	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-819697	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-516523	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-830668	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1612343	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1575676	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-830668	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-722704	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1612343	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1575676	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	39732	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	76692	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-870400	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-722704	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1689035	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1575676	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6526894563	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3137190619	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5922850352	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2862173585	shares
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16578533	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	99333	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	204092	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	76692	usd
	us-gaap	Profit Loss ProfitLoss	-1612343	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17964143	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17195238	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	101495	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	39732	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-830668	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17964143	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14796078	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	69108	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	574589	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	350652	usd
	us-gaap	Profit Loss ProfitLoss	-1575676	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15377405	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15178266	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34174	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	324589	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	164802	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-722704	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15377405	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1612343	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1575676	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	169712	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	62495	usd
	us-gaap	Accretion Expense AccretionExpense	114000	usd
	us-gaap	Accretion Expense AccretionExpense	148558	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	69108	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	18704	usd
	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	114000	usd
	bant	Gain Loss On Fee Notes Issued GainLossOnFeeNotesIssued	90000	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	99231	usd
	bant	Gain Loss On Derivative Change In Fair Market Value GainLossOnDerivativeChangeInFairMarketValue	12101	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-120602	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41013	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9080	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60392	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-23948	usd
	bant	Increase Decrease Right Of Use Lease Asset IncreaseDecreaseRightOfUseLeaseAsset	948	usd
	bant	Increase Decrease Right Of Use Lease Asset IncreaseDecreaseRightOfUseLeaseAsset	-26088	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	778683	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	408993	usd
	bant	Increase Decrease In Settlement Payable IncreaseDecreaseInSettlementPayable	32222	usd
	bant	Increase Decrease Right Of Use Lease Liability IncreaseDecreaseRightOfUseLeaseLiability	26003	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-320732	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-985226	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	99333	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	574589	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	101250	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	120000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	40741	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	151800	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	75000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	62897	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	24087	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	18000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4885	usd
	bant	Repayments Of Factoring Notes RepaymentsOfFactoringNotes	196764	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144495	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	387103	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-176237	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-598123	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	186386	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	985953	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10149	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	387830	usd
	us-gaap	Interest Paid Net InterestPaidNet	16965	usd
	bant	Issuance Of Common Stock For Conversion Of Convertible Notes And Accrued Interest IssuanceOfCommonStockForConversionOfConvertibleNotesAndAccruedInterest	95388	usd
	bant	Issuance Of Common Stock For Conversion Of Convertible Notes And Accrued Interest IssuanceOfCommonStockForConversionOfConvertibleNotesAndAccruedInterest	231787	usd
	bant	Reclassification Of Debt Premium Upon Conversion ReclassificationOfDebtPremiumUponConversion	90000	usd
	bant	Reclassification Of Debt Premium Upon Conversion ReclassificationOfDebtPremiumUponConversion	118865	usd
	bant	Original Issue Discounts Notes OriginalIssueDiscountsNotes	7500	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - <span style="font-variant: small-caps"><span style="text-decoration:underline">NATURE OF OPERATIONS</span></span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bantec, Inc. is product and service company targeting the U.S. Government, state governments, municipalities, hospitals, universities, manufacturers and other building owners. Bantec also provides product procurement, distribution, and logistics services through its wholly-owned subsidiary, Howco Distributing Co., (“Howco”) (collectively, the “Company”) to the United States Department of Defense and Defense Logistics Agency. The Company established Bantec Sanitizing in fiscal 2021, which offers sanitizing products and equipment through its new store bantec.store. Bantec Sanitizing is currently offering Bantec Sanitizing franchises for sale. The Company has operations based in Little Falls, New Jersey and Vancouver, Washington. The Company continues to seek strategic acquisitions and partnerships that offer us an opportunity to grow sales and profit.</p>
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1612343	usd
CY2023Q1	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	320732	usd
	bant	Working Capital Deficit WorkingCapitalDeficit	17060914	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	17964143	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37242529	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the allowance for bad debt on accounts receivable, reserves on inventory, valuation of intangible assets for impairment analysis, valuation of the lease liability and related right-of-use asset, valuation of stock-based compensation, valuation of redeemable preferred stock and the valuation allowance on deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
	us-gaap	Recapitalization Costs RecapitalizationCosts	2000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
	bant	Salvageable Value SalvageableValue	1461	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	20683	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	33325	usd
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	156554	usd
CY2023Q1	bant	Options Outstanding And Exercisable OptionsOutstandingAndExercisable	16423	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2240000000	shares
	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	8857222	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	192162563834	shares
	us-gaap	Earnings Per Share Potentially Dilutive Securities EarningsPerSharePotentiallyDilutiveSecurities	201,122,580,257
	bant	Shares Converted Percentage SharesConvertedPercentage	0.0499	pure
	bant	Outstanding Shares Percentage OutstandingSharesPercentage	0.0999	pure
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16423	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	17223	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2240000000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	239554150	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6720000000	shares
	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	192162563834	shares
	bant	Incremental Common Shares Attributable To Sharebased Payment Arrangements Senior Convertible Debt IncrementalCommonSharesAttributableToSharebasedPaymentArrangementsSeniorConvertibleDebt	15486087812	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	201122580257	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15725659185	shares
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On February 10, 2023 the Company filed Form DEF 14C to effect a reverse split of between 1:500 and 1:1,000 shares of common stock. The Company has determined that the reverse split will be 1:1,000. The Company expects the FINRA review to be completed before June 2023. The table below shows the Losses Per Share prior to the reverse split and following the reverse split of 1:1,000. A key assumption to the earnings per share calculation is that post-reverse split price is equal to the pre-reverse split times the number of shares from the ratio. For example: pre-reverse split price of $0.0003 times the reverse split of 1,000 is equal to $0.30.
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	1689035	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	1575676	usd
	bant	Current Weighted Average Shares Outstanding CurrentWeightedAverageSharesOutstanding	5922850352	shares
	bant	Current Weighted Average Shares Outstanding CurrentWeightedAverageSharesOutstanding	2862173585	shares
	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2023Q1	bant	Share Outstanding ShareOutstanding	5922850	shares
CY2022Q1	bant	Share Outstanding ShareOutstanding	2862174	shares
	bant	Loss Per Share LossPerShare	0.29
	bant	Loss Per Share LossPerShare	0.55
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
	us-gaap	Segment Reporting Description Of All Other Segments SegmentReportingDescriptionOfAllOtherSegments	Howco generated 99% of the consolidated sales which are primarily from department of defense. Drone LLC generated less than 1% of sales primarily to state and municipal government purchases of drones and accessories. Bantec Sanitizing Inc. had no contribution to consolidated sales of its sanitizing products for the six months ended March 31, 2023. Howco has 98% of the consolidated tangible assets, Drone has no allocated assets and Bantec Sanitizing Inc. has less than 1% of consolidated assets and the parent company has 1.4% of the consolidated tangible assets as of March 31, 2023 and additionally, there are no formal cost allocations to Howco or the other subsidiaries.
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	299350	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	419951	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	299350	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	419951	usd
	bant	Bad Debt Expense BadDebtExpense	0	usd
CY2022	bant	Bad Debt Expense BadDebtExpense	0	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	83838	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	92917	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2022Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2023Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	50000	usd
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.26	pure
CY2018Q3	bant	Settlement Agreement Relating To Past Due Charges Amount SettlementAgreementRelatingToPastDueChargesAmount	127056	usd
CY2020Q1	bant	Initial Payment Amount InitialPaymentAmount	12706	usd
CY2020Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	6500	usd
CY2020Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3850	usd
CY2022Q2	us-gaap	Payments For Fees PaymentsForFees	7042	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	5000	usd
CY2022Q3	us-gaap	Settlement Assets Current SettlementAssetsCurrent	119670	usd
CY2023Q1	us-gaap	Cash Cash	2222	usd
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	122340	usd
CY2022	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	154562	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2017-09-09
	bant	Debt Instrument Interest Rates During Period DebtInstrumentInterestRatesDuringPeriod	0.055	pure
	bant	Debt Instrument Default Interest Rate DebtInstrumentDefaultInterestRate	0.08	pure
	bant	Amortization Of Debt Discounts Premium AmortizationOfDebtDiscountsPremium	0	usd
CY2022Q4	bant	Accrued Interests AccruedInterests	621	usd
	bant	Amortization Of Debt Discounts Premium AmortizationOfDebtDiscountsPremium	19516	usd
CY2016Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7000	shares
CY2023Q1	bant	Common Stock Share Issued CommonStockShareIssued	539	shares
CY2022Q3	bant	Common Stock Share Issued CommonStockShareIssued	539	shares
CY2017Q2	bant	Debt Instrument Embedded Conversion Amount DebtInstrumentEmbeddedConversionAmount	617647	usd
CY2017Q2	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.25	pure
CY2019Q4	bant	Securities Shares Issued SecuritiesSharesIssued	1273261	shares
CY2018Q4	bant	Securities Shares Issued SecuritiesSharesIssued	101624	shares
CY2019Q4	bant	Shares Cancelled SharesCancelled	194520	shares
CY2018	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	308100	usd
CY2019	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	270320	usd
CY2022Q3	bant	Convertible Debt Balance Amount ConvertibleDebtBalanceAmount	421587	usd
CY2021Q4	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2021Q4	bant	Notes Bears Interest NotesBearsInterest	0.10	pure
CY2021Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	105000	usd
CY2022Q1	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	191826700	shares
CY2022Q4	bant	Debt Instrument Annual Principal Payments DebtInstrumentAnnualPrincipalPayments	15000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	888	usd
CY2022Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q2	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q4	bant	Conversion Shares Of Common Stock1 ConversionSharesOfCommonStock1	384804200	shares
CY2022Q4	bant	Debt Instrument Annual Principal Payments DebtInstrumentAnnualPrincipalPayments	15000	usd
CY2022Q4	bant	Accrued Interests AccruedInterests	945	usd
CY2022Q2	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q2	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q4	bant	Debt Instrument Annual Principal Payments DebtInstrumentAnnualPrincipalPayments	15000	usd
CY2022Q4	us-gaap	Debt Conversion Description DebtConversionDescription	$879
CY2022Q2	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	15000	usd
CY2022Q2	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q2	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2023Q1	bant	Accrued Interests AccruedInterests	884	usd
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	372911200	shares
CY2022Q3	bant	Debt Instrument Annual Principal Payments DebtInstrumentAnnualPrincipalPayments	15000	usd
CY2022Q3	bant	Accrued Interests AccruedInterests	871	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	372664600	shares
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000	usd
CY2022Q4	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q4	bant	Accrued Interests AccruedInterests	748	usd
CY2022Q4	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q3	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q4	bant	Debt Instrument Principal Amount DebtInstrumentPrincipalAmount	15000	usd
CY2022Q4	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2022Q4	bant	Accrued Interests AccruedInterests	497	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000	usd
CY2023Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2023Q1	bant	Accrued Interests AccruedInterests	306	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000	usd
CY2023Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2023Q1	bant	Accrued Interests AccruedInterests	127	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000	usd
CY2023Q1	bant	Conversion Discount ConversionDiscount	0.50	pure
CY2023Q1	bant	Accrued Interests AccruedInterests	64	usd
	bant	Frondeur Notes FrondeurNotes	105000	usd
CY2022	bant	Frondeur Notes FrondeurNotes	105000	usd
	bant	Deposit Liabilitie Accrued Interest1 DepositLiabilitieAccruedInterest1	3173	usd
CY2022	bant	Deposit Liabilitie Accrued Interest1 DepositLiabilitieAccruedInterest1	3631	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2023Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.50	pure
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4000	usd
CY2022Q3	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q3	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q4	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q4	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2022Q4	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2023Q1	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2023Q1	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
CY2023Q1	bant	Convertible Note Issuance ConvertibleNoteIssuance	4000	usd
	bant	Agreement Owned Amount AgreementOwnedAmount	44000	usd
CY2022	bant	Agreement Owned Amount AgreementOwnedAmount	20000	usd
CY2018Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	90000	usd
CY2018Q4	bant	Vendor Settlement VendorSettlement	161700	usd
CY2018Q4	us-gaap	Debt Conversion Description DebtConversionDescription	The note bears interest at 5%, matures on June 30, 2019 and is convertible into the Company’s common stock at 50% of the lowest closing bid price during the 20 trading days immediately preceding the notice of conversion.
CY2018Q4	bant	Debt Premium Charge To Interest Expense DebtPremiumChargeToInterestExpense	90000	usd
CY2023Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	90000	usd
CY2022Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	90000	usd
CY2023Q1	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	574759	usd
CY2022Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	615500	usd
CY2023Q1	bant	Debt Instrument Discount Amount DebtInstrumentDiscountAmount	100353	usd
CY2022Q3	bant	Debt Instrument Discount Amount DebtInstrumentDiscountAmount	270064	usd
CY2023Q1	bant	Debt Instrument Total DebtInstrumentTotal	474406	usd
CY2022Q3	bant	Debt Instrument Total DebtInstrumentTotal	345436	usd
CY2023Q1	bant	Less Current Portions LessCurrentPortions	324406	usd
CY2022Q3	bant	Less Current Portions LessCurrentPortions	217897	usd
CY2023Q1	bant	Noncurrent Noncurrent	150000	usd
CY2022Q3	bant	Noncurrent Noncurrent	127539	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	169712	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	45816	usd
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	150000	usd
	bant	Classified Current Interest ClassifiedCurrentInterest	0	usd
CY2022	bant	Classified Current Interest ClassifiedCurrentInterest	22461	usd
CY2021	bant	Number Of Notes Payable NumberOfNotesPayable	seven
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	17500	usd
CY2021	bant	Service Vendor Fee ServiceVendorFee	-2500	usd
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
	bant	Service Arrangement ServiceArrangement	17500	usd
CY2022	bant	Service Arrangement ServiceArrangement	17500	usd
	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	0.0002
	bant	Debt Instrument Convertible Conversion Price DebtInstrumentConvertibleConversionPrice	0.50	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.50	pure
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	101368	usd
CY2023Q1	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	461440	usd
CY2022Q3	bant	Additional Paid In Capital Including Dividends AdditionalPaidInCapitalIncludingDividends	360072	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	13440	usd
CY2023Q1	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	76692	usd
CY2023Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.5
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0002
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.50	pure
CY2023Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	224000	usd
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.22	pure
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Capital Shares Reserved For Future Issuance PreferredStockCapitalSharesReservedForFutureIssuance	3999750	shares
	bant	Common Stock Dividend CommonStockDividend	0.99
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6993994532	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4407320832	shares
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On February 10, 2023, the Company submitted Form Def 14C announcing that the stockholders of record have approved by written consent to amend the Certificate of Incorporation to effect a reverse split of the Company’s common stock in a range between 1:500 and 1:1,000. The Company has determined to fix the reverse split ratio to 1:1,000 and will file the amendment in Delaware (it’s state of registration).
CY2022Q3	bant	Issuance Settled Amount Due Description IssuanceSettledAmountDueDescription	The offering provides for the issuance of up to 5,000,000,000 shares of common stock at a price of $.0002, under subscriptions.
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	496667000	shares
	bant	Offering And Recieved OfferingAndRecieved	99333	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2090006700	shares
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	90000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	69108	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16423	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220
CY2022	bant	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P1Y11M19D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16423	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220
CY2022Q4	bant	Weighted Average Remaining Contractual Term Years Outstanding Beginning WeightedAverageRemainingContractualTermYearsOutstandingBeginning	P1Y8M19D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16423	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	220
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M19D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2240000000	shares
CY2021Q3	bant	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	0.0002
CY2022	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Begining WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableBegining	P6Y9M
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0002
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	448000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2240000000	shares
CY2022Q4	bant	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	0.0002
CY2022Q4	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisable Ending WeightedAverageRemainingContractualTermYearsOutstandingAndExercisableEnding	P6Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0002
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	112000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2240000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0002
	bant	Weighted Average Remaining Contractual Term Years Outstanding And Exercisables Ending WeightedAverageRemainingContractualTermYearsOutstandingAndExercisablesEnding	P6Y3M
CY2023Q1	bant	Weighted Average Grant Date Fair Value Outstanding And Exercisable Endingin Dollars WeightedAverageGrantDateFairValueOutstandingAndExercisableEndinginDollars	0.0002
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	112000000000	usd
CY2023Q1	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.10	pure
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.90	pure
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
	bant	Employees Contribution Plans Term EmployeesContributionPlansTerm	P1Y
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	2123	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	3517	usd
CY2016Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	370000	usd
	us-gaap	Loss On Contract Termination LossOnContractTermination	2500000	usd
CY2019Q3	bant	Annual Salary AnnualSalary	624000	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	24000	usd
	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	$3,000
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	36821330	shares
CY2022	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	119670	shares
CY2023Q1	us-gaap	Cash Cash	2222	usd
CY2019Q2	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisions	218637	usd
CY2019Q3	bant	Past Due Amounts PastDueAmounts	59000	usd
CY2020Q4	bant	Lawsuit Seeking Payment lawsuitSeekingPayment	276430	usd
CY2020Q4	bant	Finance Charge FinanceCharge	40212	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	The agreement has an initial term of three years with one year renewals.
CY2017Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	360000	usd
CY2020Q2	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	On April 16, 2020 the Company’s subsidiary Howco renewed its office and warehouse lease in Vancouver, WA for a term commencing on June 1, 2020 extending through June 1, 2023 at an initial monthly rent of approximately $5,154.
CY2023Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	156554	usd
CY2023Q1	bant	Operating Lease At Inception OperatingLeaseAtInception	156554	usd
CY2022Q3	bant	Operating Lease At Inception OperatingLeaseAtInception	156554	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	149111	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122986	usd
CY2023Q1	bant	Right Of Use Asset RightOfUseAsset	7443	usd
CY2022Q3	bant	Right Of Use Asset RightOfUseAsset	33568	usd
CY2023Q1	bant	Operating Lease Liabilities At Inception OperatingLeaseLiabilitiesAtInception	156554	usd
CY2022Q3	bant	Operating Lease Liabilities At Inception OperatingLeaseLiabilitiesAtInception	156554	usd
CY2023Q1	bant	Reduction Of Lease Liabilities ReductionOfLeaseLiabilities	148884	usd
CY2022Q3	bant	Reduction Of Lease Liabilities ReductionOfLeaseLiabilities	122079	usd
CY2023Q1	bant	Total Lease Liabilities Related To Rou TotalLeaseLiabilitiesRelatedToRou	7670	usd
CY2022Q3	bant	Total Lease Liabilities Related To Rou TotalLeaseLiabilitiesRelatedToRou	34475	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	7640	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	42929	usd
CY2022Q3	bant	Discount To Fair Value DiscountToFairValue	8454	usd
CY2023Q1	bant	Total Lease Liability Rou TotalLeaseLiabilityROU	7640	usd
CY2022Q3	bant	Total Lease Liability Rou TotalLeaseLiabilityROU	34475	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7670	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7670	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	38991	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	34643	usd
CY2019Q4	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	In December 2019, the Company relocated its primary office to 195 Paterson Avenue, Little Falls, New Jersey, under a one-year lease with a renewal option having monthly payments of $500.
CY2023Q1	us-gaap	Advance Rent AdvanceRent	700	usd
	bant	Employees Earned Salary EmployeesEarnedSalary	0	usd
	bant	Employees Earned Salary EmployeesEarnedSalary	0	usd
	bant	Federally Insured Limit Amount FederallyInsuredLimitAmount	250000	usd
	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	4509	usd
	bant	Concentrations Of Foreign Sales ConcentrationsOfForeignSales	0	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	130400	usd
CY2023Q1	bant	Total Paid Amount TotalPaidAmount	90000	usd
	bant	Gain Loss On Derivative Change In Fair Market Value GainLossOnDerivativeChangeInFairMarketValue		usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	bant	Sharebased Compensation Arrangement By Sharebased Payment Award Outstanding And Exercisable Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOutstandingAndExercisableWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	bant	Less Current Portion LessCurrentPortion		usd
CY2022Q3	bant	Less Current Portion LessCurrentPortion		usd
CY2023Q1	bant	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent		usd
CY2022Q3	bant	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001704795

Files In Submission

Name	View Source	Status
0001213900-23-039539-index-headers.html	Edgar Link	pending
0001213900-23-039539-index.html	Edgar Link	pending
0001213900-23-039539.txt	Edgar Link	pending
0001213900-23-039539-xbrl.zip	Edgar Link	pending
bant-20230331.xsd	Edgar Link	pending
bant-20230331_cal.xml	Edgar Link	unprocessable
bant-20230331_lab.xml	Edgar Link	unprocessable
bant-20230331_def.xml	Edgar Link	unprocessable
f10q0323ex31-1_bantecinc.htm	Edgar Link	pending
f10q0323ex31-2_bantecinc.htm	Edgar Link	pending
f10q0323ex32-1_bantecinc.htm	Edgar Link	pending
f10q0323_bantec.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
bant-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_bantec_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BANT
Bantec, Inc. Stock $bant

2023 Q2 Form 10-Q Financial Statement

#000121390023039539 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT Bantec, Inc. Stock $bant

2023 Q2 Form 10-Q Financial Statement

#000121390023039539 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANT
Bantec, Inc. Stock $bant